JLK, Inc. (KOSDAQ:322510)

Market Cap	107.18B
Revenue (ttm)	2.61B
Net Income (ttm)	-12.32B
Shares Out	25.19M
EPS (ttm)	-516.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,990
Average Volume	114,031
Open	4,340.00
Previous Close	4,255.00
Day's Range	4,310.00 - 4,455.00
52-Week Range	4,235.00 - 9,700.00
Beta	1.36
RSI	27.37
Earnings Date	Nov 14, 2025

About JLK, Inc.

JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coro...

• Industry: Conglomerates
• Sector: Industrials
• CEO: Dongmin Kim
• Employees: 74
• Stock Exchange: KOSDAQ
• Ticker Symbol: 322510

Financial Performance

In 2024, JLK, Inc.'s revenue was 1.43 billion, a decrease of -42.65% compared to the previous year's 2.49 billion. Losses were -13.45 billion, 83.7% more than in 2023.